{"id": "article-19223_0", "title": "Cervical Screening -- Introduction", "content": "Cervical cancer is a significant women's health\u00a0problem worldwide.\u00a0Most cases of cervical cancer occur in developing countries that have ineffective screening programs. The incidence and mortality of cervical cancer in the United States have been decreasing in the past 30 years\u00a0due to\u00a0widespread screening. In the United States, cervical cancer diagnosis is usually in women who have never received screening or received inadequate screening. [1] Human papillomavirus (HPV) is one of the most common risk factors for cervical cancer. There are over 100 different strains of HPV, and those considered of high risk\u00a0are involved in the etiology of cancer.\u00a0Screening guidelines for cervical cancer have\u00a0been evaluated\u00a0and adjusted considering the time required for disease progression. Screening methods of cervical cancer include cytology and HPV testing. [2]", "contents": "Cervical Screening -- Introduction. Cervical cancer is a significant women's health\u00a0problem worldwide.\u00a0Most cases of cervical cancer occur in developing countries that have ineffective screening programs. The incidence and mortality of cervical cancer in the United States have been decreasing in the past 30 years\u00a0due to\u00a0widespread screening. In the United States, cervical cancer diagnosis is usually in women who have never received screening or received inadequate screening. [1] Human papillomavirus (HPV) is one of the most common risk factors for cervical cancer. There are over 100 different strains of HPV, and those considered of high risk\u00a0are involved in the etiology of cancer.\u00a0Screening guidelines for cervical cancer have\u00a0been evaluated\u00a0and adjusted considering the time required for disease progression. Screening methods of cervical cancer include cytology and HPV testing. [2]"}
{"id": "article-19223_1", "title": "Cervical Screening -- Specimen Collection", "content": "Cervical cancer screening can be achieved using two methods the liquid-based or the conventional method. Both methods collect cells from the transformation zone of the cervix. The liquid-based method involves transferring cells into a vial of preservatives, which can undergoes further processing in a laboratory. The liquid-based technique allows for easier interpretation, filtering of excess debris, and more importantly\u00a0fewer unsatisfactory results.\u00a0 Another advantage of using the liquid-based technique includes using a single specimen to perform cytology, HPV testing and gonorrhea and chlamydia testing. [3]", "contents": "Cervical Screening -- Specimen Collection. Cervical cancer screening can be achieved using two methods the liquid-based or the conventional method. Both methods collect cells from the transformation zone of the cervix. The liquid-based method involves transferring cells into a vial of preservatives, which can undergoes further processing in a laboratory. The liquid-based technique allows for easier interpretation, filtering of excess debris, and more importantly\u00a0fewer unsatisfactory results.\u00a0 Another advantage of using the liquid-based technique includes using a single specimen to perform cytology, HPV testing and gonorrhea and chlamydia testing. [3]"}
{"id": "article-19223_2", "title": "Cervical Screening -- Specimen Collection", "content": "In contrast, the conventional method of screening involves transferring cervical cells from the transformation zone directly to a slide and then fixing the specimen. Specimen interpretation may be difficult with the presence of blood, discharge and lubricant use. [4] Both methods of specimen collection have undergone study, and there was no statistical difference in the specificity or sensitivity for detecting cervical intraepithelial neoplasia. [5] [6]", "contents": "Cervical Screening -- Specimen Collection. In contrast, the conventional method of screening involves transferring cervical cells from the transformation zone directly to a slide and then fixing the specimen. Specimen interpretation may be difficult with the presence of blood, discharge and lubricant use. [4] Both methods of specimen collection have undergone study, and there was no statistical difference in the specificity or sensitivity for detecting cervical intraepithelial neoplasia. [5] [6]"}
{"id": "article-19223_3", "title": "Cervical Screening -- Indications", "content": "Cervical cancer screening guidelines have been established for the general population by three major organizations, including the American Cancer Society, the American Society for Colposcopy and Cervical Pathology and the American Society for Clinical Pathology.", "contents": "Cervical Screening -- Indications. Cervical cancer screening guidelines have been established for the general population by three major organizations, including the American Cancer Society, the American Society for Colposcopy and Cervical Pathology and the American Society for Clinical Pathology."}
{"id": "article-19223_4", "title": "Cervical Screening -- Indications", "content": "For females younger than 21 years,\u00a0no screening is recommended.", "contents": "Cervical Screening -- Indications. For females younger than 21 years,\u00a0no screening is recommended."}
{"id": "article-19223_5", "title": "Cervical Screening -- Indications", "content": "In addition, for women aged 21-29 years, recommendations include cytology without HPV testing. Human papilloma virus is most commonly diagnosed in teenagers and young females in their twenties. Therefore, pap smears in this age group will\u00a0cause\u00a0abnormal findings. The majority of young women have an effective immune response that will clear the infection in 8 months or decrease the viral loads to undetectable levels. [5] The incidence of cervical cancer before age 20 is\u00a0low (0.1% cases), and data has not illustrated that screening is effective in this age group. [7]", "contents": "Cervical Screening -- Indications. In addition, for women aged 21-29 years, recommendations include cytology without HPV testing. Human papilloma virus is most commonly diagnosed in teenagers and young females in their twenties. Therefore, pap smears in this age group will\u00a0cause\u00a0abnormal findings. The majority of young women have an effective immune response that will clear the infection in 8 months or decrease the viral loads to undetectable levels. [5] The incidence of cervical cancer before age 20 is\u00a0low (0.1% cases), and data has not illustrated that screening is effective in this age group. [7]"}
{"id": "article-19223_6", "title": "Cervical Screening -- Indications", "content": "For women aged 30-65 years, recommendations include cytology alone every three years or cytology with HPV testing every five years.", "contents": "Cervical Screening -- Indications. For women aged 30-65 years, recommendations include cytology alone every three years or cytology with HPV testing every five years."}
{"id": "article-19223_7", "title": "Cervical Screening -- Indications", "content": "For women who underwent total hysterectomy with no history of cervical dysplasia or cancer in the past 20 years, no screening is recommended.", "contents": "Cervical Screening -- Indications. For women who underwent total hysterectomy with no history of cervical dysplasia or cancer in the past 20 years, no screening is recommended."}
{"id": "article-19223_8", "title": "Cervical Screening -- Indications", "content": "For women older than 65 years, no screening is necessary after adequate prior screening results. Two consecutive negative cytology results with negative HPV testing or three consecutive negative cytology results constitutes adequate previous prior screening results. Women with a prior history of cervical dysplasia or adenocarcinoma should continue screening for 20 years. [6]", "contents": "Cervical Screening -- Indications. For women older than 65 years, no screening is necessary after adequate prior screening results. Two consecutive negative cytology results with negative HPV testing or three consecutive negative cytology results constitutes adequate previous prior screening results. Women with a prior history of cervical dysplasia or adenocarcinoma should continue screening for 20 years. [6]"}
{"id": "article-19223_9", "title": "Cervical Screening -- Indications", "content": "Primary HPV testing for cervical cancer screening has specific indications established by ASCCP and Society of Gynecology Oncology [SGO]. [6]", "contents": "Cervical Screening -- Indications. Primary HPV testing for cervical cancer screening has specific indications established by ASCCP and Society of Gynecology Oncology [SGO]. [6]"}
{"id": "article-19223_10", "title": "Cervical Screening -- Indications", "content": "Primary HPV testing should not be used in females younger than 25 years, re-screening after a negative primary HPV test should not occur earlier than\u00a0three years and genotype should\u00a0be completed for all positive HPV results. There are no clear guidelines for using primary HPV testing for immunocompromised and HIV positive females. [6] If clinicians use primary HPV testing, only one test has been approved and should be used for this purpose. [6]", "contents": "Cervical Screening -- Indications. Primary HPV testing should not be used in females younger than 25 years, re-screening after a negative primary HPV test should not occur earlier than\u00a0three years and genotype should\u00a0be completed for all positive HPV results. There are no clear guidelines for using primary HPV testing for immunocompromised and HIV positive females. [6] If clinicians use primary HPV testing, only one test has been approved and should be used for this purpose. [6]"}
{"id": "article-19223_11", "title": "Cervical Screening -- Potential Diagnosis", "content": "In the United States, screening results are reported using the Bethesda System of cervical cytology. Reports include specimen type, specimen adequacy, interpretation, adjunctive testing, and computer-assisted interpretation of cervical cytology. [6] The specimen type will define the method of collection used. Specimen adequacy will notify the clinician if the specimen was satisfactory for evaluation or if the specimen was rejected and not processed. Reports will also describe the presence or absence of the transformation zone and whether the clinician will need to repeat the specimen collection. If the specimen analysis was by an automated device, the device must be included in the report.", "contents": "Cervical Screening -- Potential Diagnosis. In the United States, screening results are reported using the Bethesda System of cervical cytology. Reports include specimen type, specimen adequacy, interpretation, adjunctive testing, and computer-assisted interpretation of cervical cytology. [6] The specimen type will define the method of collection used. Specimen adequacy will notify the clinician if the specimen was satisfactory for evaluation or if the specimen was rejected and not processed. Reports will also describe the presence or absence of the transformation zone and whether the clinician will need to repeat the specimen collection. If the specimen analysis was by an automated device, the device must be included in the report."}
{"id": "article-19223_12", "title": "Cervical Screening -- Normal and Critical Findings", "content": "A normal Pap test result begins with a statement of adequacy, followed by \u201cnegative for intraepithelial lesion or malignancy\u201d (NILM). Negative for intraepithelial lesion or malignancy findings include: Non-neoplastic cellular changes Reactive cellular changes Microorganisms\u00a0including\u00a0the following: Trichomonas vaginalis, Candida species, bacterial vaginosis, actinomyces and cellular changes\u00a0due to\u00a0Herpes simplex virus and Cytomegalovirus", "contents": "Cervical Screening -- Normal and Critical Findings. A normal Pap test result begins with a statement of adequacy, followed by \u201cnegative for intraepithelial lesion or malignancy\u201d (NILM). Negative for intraepithelial lesion or malignancy findings include: Non-neoplastic cellular changes Reactive cellular changes Microorganisms\u00a0including\u00a0the following: Trichomonas vaginalis, Candida species, bacterial vaginosis, actinomyces and cellular changes\u00a0due to\u00a0Herpes simplex virus and Cytomegalovirus"}
{"id": "article-19223_13", "title": "Cervical Screening -- Normal and Critical Findings", "content": "Concerning findings include epithelial cell abnormalities and endometrial cells in women\u00a0aged 45 years old or older. Endometrial cells found during cervical cancer screening may raise concern for endometrial hyperplasia, and\u00a0further workup may be indicated. Epithelial cell abnormalities are divided\u00a0into two categories including squamous cell and glandular cell abnormalities. Squamous cell findings include: Atypical squamous cells of undetermined significance (ASCUS) or cannot rule out high grade (ASC-H) Low grade squamous intraepithelial lesion (LSIL) or cervical intraepithelial neoplasia (CIN1). These are mild, subtle cell changes, and most go away without treatment High-grade squamous intraepithelial lesions (HSIL) or CIN 2 or 3. Moderate and severe cell changes which require further testing or treatment Squamous cell carcinoma of the cervix Glandular cell findings include:", "contents": "Cervical Screening -- Normal and Critical Findings. Concerning findings include epithelial cell abnormalities and endometrial cells in women\u00a0aged 45 years old or older. Endometrial cells found during cervical cancer screening may raise concern for endometrial hyperplasia, and\u00a0further workup may be indicated. Epithelial cell abnormalities are divided\u00a0into two categories including squamous cell and glandular cell abnormalities. Squamous cell findings include: Atypical squamous cells of undetermined significance (ASCUS) or cannot rule out high grade (ASC-H) Low grade squamous intraepithelial lesion (LSIL) or cervical intraepithelial neoplasia (CIN1). These are mild, subtle cell changes, and most go away without treatment High-grade squamous intraepithelial lesions (HSIL) or CIN 2 or 3. Moderate and severe cell changes which require further testing or treatment Squamous cell carcinoma of the cervix Glandular cell findings include:"}
{"id": "article-19223_14", "title": "Cervical Screening -- Normal and Critical Findings", "content": "Atypical glandular cells of undetermined significance (AGUS), Atypical glandular cells Not otherwise specified\u00a0(NOS) Favor neoplasia Endocervical adenocarcinoma in situ or adenocarcinoma Epithelial cell abnormalities will need further workup and treatment based on the patient\u2019s age and medical history. [6]", "contents": "Cervical Screening -- Normal and Critical Findings. Atypical glandular cells of undetermined significance (AGUS), Atypical glandular cells Not otherwise specified\u00a0(NOS) Favor neoplasia Endocervical adenocarcinoma in situ or adenocarcinoma Epithelial cell abnormalities will need further workup and treatment based on the patient\u2019s age and medical history. [6]"}
{"id": "article-19223_15", "title": "Cervical Screening -- Interfering Factors", "content": "Specific populations may have different screening indications due to risk factors that have associations with cervical cancer. Women diagnosed with HIV, immunocompromised states, exposure to diethylstilbestrol in utero and those treated previously for CIN 2, CIN 3 or cervical cancer will require more frequent screening. [6]", "contents": "Cervical Screening -- Interfering Factors. Specific populations may have different screening indications due to risk factors that have associations with cervical cancer. Women diagnosed with HIV, immunocompromised states, exposure to diethylstilbestrol in utero and those treated previously for CIN 2, CIN 3 or cervical cancer will require more frequent screening. [6]"}
{"id": "article-19223_16", "title": "Cervical Screening -- Patient Safety and Education", "content": "Patients\u00a0should receive education regarding the limitations of screening and appropriate\u00a0follow-up intervals. Annual well-woman exams should be recommended even if cervical cancer screening is not performed at the visit. [6] [8]", "contents": "Cervical Screening -- Patient Safety and Education. Patients\u00a0should receive education regarding the limitations of screening and appropriate\u00a0follow-up intervals. Annual well-woman exams should be recommended even if cervical cancer screening is not performed at the visit. [6] [8]"}
{"id": "article-19223_17", "title": "Cervical Screening -- Patient Safety and Education", "content": "Protection from cervical cancer is the primary goal of screening. However, patients should receive counsel about other methods of prevention. Patients should be counseled on the risks factors, smoking cessation, safe sex practice to limit exposure to sexually transmitted infections and HPV vaccination. Administration of the HPV vaccine will not affect the frequency of screening and patient should be educated to return for age-based screening.", "contents": "Cervical Screening -- Patient Safety and Education. Protection from cervical cancer is the primary goal of screening. However, patients should receive counsel about other methods of prevention. Patients should be counseled on the risks factors, smoking cessation, safe sex practice to limit exposure to sexually transmitted infections and HPV vaccination. Administration of the HPV vaccine will not affect the frequency of screening and patient should be educated to return for age-based screening."}
{"id": "article-19223_18", "title": "Cervical Screening -- Clinical Significance", "content": "Cervical cancer screening is one of the best cancer prevention achievements. However, there continue to be women who are not compliant with screening recommendations. Many die from this preventable cancer due to inadequate screening. Public health efforts are available to increase access to screening with appropriate follow-up. [9]", "contents": "Cervical Screening -- Clinical Significance. Cervical cancer screening is one of the best cancer prevention achievements. However, there continue to be women who are not compliant with screening recommendations. Many die from this preventable cancer due to inadequate screening. Public health efforts are available to increase access to screening with appropriate follow-up. [9]"}
{"id": "article-19223_19", "title": "Cervical Screening -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cervical Screening -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}